ArticleMayo Clinic proceedings. Innovations, quality & outcomes2025
Severe Alveolar Bone Loss as a Rare Manifestation of Suspected Intestinal Behçet Disease: A Case Report.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral ulcers commonly occur in Behçet disease, but severe alveolar bone loss is rarely documented. We report a case where marked periodontal destruction preceded the diagnosis of suspected intestinal Behçet disease. A 21-year-old man presented with extensive palatal ulcers and severe maxillary alveolar bone loss extending to the root apices. Radiographic examination revealed localized bone destruction confined to the palatal region. Subsequent evaluation revealed intestinal lesions characteristic of Behçet disease. A combination of systemic medications (prednisolone, mesalazine, and infliximab) and periodontal care stabilized both oral and intestinal conditions. This case highlights that severe alveolar bone destruction can manifest as a complication of intestinal Behçet disease, underscoring the importance of thorough oral examinations and integrated medical-dental care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.